Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide in Adolescents With Obesity After Sleeve Gastrectomy
NCT04883346Phase 2Completed
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Start
- Jun 2021
- Primary completion
- Mar 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of liraglutide in obesity, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development. Started Jun 2021; status: completed.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT04883346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04883346.